Wellington Management Group LLP 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-10-08 08:36 am Sale |
2021-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
Wellington Management Group LLP | 0 0.000% |
-578,560![]() (Position Closed) |
Filing |
2021-03-10 07:17 am Purchase |
2021-02-26 | 13G | Viridian Therapeutics, Inc. VRDN |
Wellington Management Group LLP | 578,560 11.100% |
578,560![]() (New Position) |
Filing |